Zynex Recommandation moyenne
Quel est le Recommandation moyenne de Zynex?
Le Recommandation moyenne de Zynex, Inc. est 2.00
Quelle est la définition de Recommandation moyenne?
La moyenne recommandée est la moyenne des évaluations des actions par les analystes allant de 1,0 (achat fort) à 5,0 (vente forte).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Recommandation moyenne des entreprises dans Health Care secteur sur SSE par rapport à Zynex
Que fait Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Entreprises avec recommandation moyenne similaire à Zynex
- Cabot Oil & Gas a Recommandation moyenne de 1.96
- Truist a Recommandation moyenne de 1.96
- Delta Air Lines a Recommandation moyenne de 1.96
- Discover Services a Recommandation moyenne de 1.96
- United Micro Electronics a Recommandation moyenne de 1.96
- Tapestry Inc a Recommandation moyenne de 1.97
- Zynex a Recommandation moyenne de 2.00
- Trip.com Ltd a Recommandation moyenne de 2.03
- Sherwin-Williams Co a Recommandation moyenne de 2.03
- Canadian Pacific Kansas City a Recommandation moyenne de 2.03
- Arista Networks Inc a Recommandation moyenne de 2.03
- Anheuser-Busch InBev SA/NV a Recommandation moyenne de 2.03
- Celanese Corp a Recommandation moyenne de 2.04